AKT1 and fatty liver disease: In conclusion, crosstalk between β‐AR and insulin signaling may contribute to HFD‐induced hepatic steatosis through ERK1/2‐ and AKT‐mediated hyperactivation of the mTORC1/S6K1 axis.